These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27481745)

  • 1. IgG2 as an independent risk factor for mortality in patients with community-acquired pneumonia.
    de la Torre MC; Palomera E; Serra-Prat M; Güell E; Yébenes JC; Bermejo-Martín JF; Almirall J
    J Crit Care; 2016 Oct; 35():115-9. PubMed ID: 27481745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
    Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
    Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
    Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM levels in plasma predict outcome in severe pandemic influenza.
    Justel M; Socias L; Almansa R; Ramírez P; Gallegos MC; Fernandez V; Gordon M; Andaluz-Ojeda D; Nogales L; Rojo S; Vallés J; Estella A; Loza A; León C; Lopez-Mestanza C; Blanco J; Berezo JÁ; Rosich S; Cillòniz C; Torres A; de Lejarazu RO; Martin-Loeches I; Bermejo-Martin JF
    J Clin Virol; 2013 Nov; 58(3):564-7. PubMed ID: 24076102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulins in the infected and convalescent phases in community-acquired pneumonia.
    de la Torre MC; Bolíbar I; Vendrell M; de Gracia J; Vendrell E; Rodrigo MJ; Boquet X; Torrebadella P; Yébenes JC; Serra-Prat M; Rello J; Torres A; Almirall J
    Respir Med; 2013 Dec; 107(12):2038-45. PubMed ID: 24084059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of prognosis by markers in community-acquired pneumonia.
    Viasus D; Simonetti A; Garcia-Vidal C; Carratalà J
    Expert Rev Anti Infect Ther; 2013 Sep; 11(9):917-29. PubMed ID: 24053273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission.
    Salluh JIF; Rabello LSCF; Rosolem MM; Soares M; Bozza FA; Verdeal JCR; Mello GW; Castro Faria Neto HC; Lapa E Silva JR; Bozza PT
    J Crit Care; 2011 Oct; 26(5):496-501. PubMed ID: 21454038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
    Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.
    Valencia M; Badia JR; Cavalcanti M; Ferrer M; Agustí C; Angrill J; García E; Mensa J; Niederman MS; Torres A
    Chest; 2007 Aug; 132(2):515-22. PubMed ID: 17505026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of immunoglobulins and severity of community-acquired pneumonia.
    de la Torre MC; Torán P; Serra-Prat M; Palomera E; Güell E; Vendrell E; Yébenes JC; Torres A; Almirall J
    BMJ Open Respir Res; 2016; 3(1):e000152. PubMed ID: 27933180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.
    Salluh JIF; Bozza FA; Soares M; Verdeal JCR; Castro-Faria-Neto HC; Lapa E Silva JR; Bozza PT
    Chest; 2008 Nov; 134(5):947-954. PubMed ID: 18753464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
    Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
    Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
    Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
    Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality.
    Méndez R; Menéndez R; Amara-Elori I; Feced L; Piró A; Ramírez P; Sempere A; Ortega A; Bermejo-Martín JF; Torres A
    J Infect; 2019 Jun; 78(6):423-431. PubMed ID: 30965065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.